These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 19650108)

  • 1. Runx2 and bone morphogenic protein 2 regulate the expression of an alternative Lef1 transcript during osteoblast maturation.
    Hoeppner LH; Secreto F; Jensen ED; Li X; Kahler RA; Westendorf JJ
    J Cell Physiol; 2009 Nov; 221(2):480-9. PubMed ID: 19650108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lef1DeltaN binds beta-catenin and increases osteoblast activity and trabecular bone mass.
    Hoeppner LH; Secreto FJ; Razidlo DF; Whitney TJ; Westendorf JJ
    J Biol Chem; 2011 Apr; 286(13):10950-9. PubMed ID: 21270130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphoid enhancer factor-1 and beta-catenin inhibit Runx2-dependent transcriptional activation of the osteocalcin promoter.
    Kahler RA; Westendorf JJ
    J Biol Chem; 2003 Apr; 278(14):11937-44. PubMed ID: 12551949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wnt/β-catenin pathway regulates bone morphogenetic protein (BMP2)-mediated differentiation of dental follicle cells.
    Silvério KG; Davidson KC; James RG; Adams AM; Foster BL; Nociti FH; Somerman MJ; Moon RT
    J Periodontal Res; 2012 Jun; 47(3):309-19. PubMed ID: 22150562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of LEF1 with TAZ is necessary for the osteoblastogenic activity of Wnt3a.
    Kida J; Hata K; Nakamura E; Yagi H; Takahata Y; Murakami T; Maeda Y; Nishimura R
    Sci Rep; 2018 Jul; 8(1):10375. PubMed ID: 29991769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocyte enhancer-binding factor 1 (Lef1) inhibits terminal differentiation of osteoblasts.
    Kahler RA; Galindo M; Lian J; Stein GS; van Wijnen AJ; Westendorf JJ
    J Cell Biochem; 2006 Apr; 97(5):969-83. PubMed ID: 16267835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell cycle related modulations in Runx2 protein levels are independent of lymphocyte enhancer-binding factor 1 (Lef1) in proliferating osteoblasts.
    Galindo M; Kahler RA; Teplyuk NM; Stein JL; Lian JB; Stein GS; Westendorf JJ; van Wijnen AJ
    J Mol Histol; 2007 Oct; 38(5):501-6. PubMed ID: 17885813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma.
    Qiang YW; Barlogie B; Rudikoff S; Shaughnessy JD
    Bone; 2008 Apr; 42(4):669-80. PubMed ID: 18294945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of an LRP5 cytoplasmic SNP on Wnt signaling and osteoblastic differentiation.
    Guo J; Cooper LF
    Bone; 2007 Jan; 40(1):57-67. PubMed ID: 16956801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BMP2 protein regulates osteocalcin expression via Runx2-mediated Atf6 gene transcription.
    Jang WG; Kim EJ; Kim DK; Ryoo HM; Lee KB; Kim SH; Choi HS; Koh JT
    J Biol Chem; 2012 Jan; 287(2):905-15. PubMed ID: 22102412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation-inducing factor-1 alters canonical Wnt signaling and suppresses alkaline phosphatase expression in osteoblast-like cell lines.
    Matsuzaki E; Takahashi-Yanaga F; Miwa Y; Hirata M; Watanabe Y; Sato N; Morimoto S; Hirofuji T; Maeda K; Sasaguri T
    J Bone Miner Res; 2006 Aug; 21(8):1307-16. PubMed ID: 16869729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-cadherin interacts with axin and LRP5 to negatively regulate Wnt/beta-catenin signaling, osteoblast function, and bone formation.
    Haÿ E; Laplantine E; Geoffroy V; Frain M; Kohler T; Müller R; Marie PJ
    Mol Cell Biol; 2009 Feb; 29(4):953-64. PubMed ID: 19075000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the ectodomain-releasing protease ADAM17 is directly regulated by the osteosarcoma and bone-related transcription factor RUNX2.
    Araya HF; Sepulveda H; Lizama CO; Vega OA; Jerez S; Briceño PF; Thaler R; Riester SM; Antonelli M; Salazar-Onfray F; Rodríguez JP; Moreno RD; Montecino M; Charbonneau M; Dubois CM; Stein GS; van Wijnen AJ; Galindo MA
    J Cell Biochem; 2018 Nov; 119(10):8204-8219. PubMed ID: 29923217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OSTM1 regulates beta-catenin/Lef1 interaction and is required for Wnt/beta-catenin signaling.
    Feigin ME; Malbon CC
    Cell Signal; 2008 May; 20(5):949-57. PubMed ID: 18296023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paeonolide as a Novel Regulator of Core-Binding Factor Subunit Alpha-1 in Bone-Forming Cells.
    Park KR; Lee JY; Cho M; Hong JT; Yun HM
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34066458
    [No Abstract]   [Full Text] [Related]  

  • 16. Wnt3a induces the expression of acetylcholinesterase during osteoblast differentiation via the Runx2 transcription factor.
    Xu ML; Bi CWC; Liu EYL; Dong TTX; Tsim KWK
    J Biol Chem; 2017 Jul; 292(30):12667-12678. PubMed ID: 28607150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. YY1 represses the transcriptional activity of Runx2 in C2C12 cells.
    Jeong HM; Choi YH; Lee SH; Lee KY
    Mol Cell Endocrinol; 2014 Mar; 383(1-2):103-10. PubMed ID: 24325869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wnt/β-catenin signaling activates bone morphogenetic protein 2 expression in osteoblasts.
    Zhang R; Oyajobi BO; Harris SE; Chen D; Tsao C; Deng HW; Zhao M
    Bone; 2013 Jan; 52(1):145-56. PubMed ID: 23032104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Collagen 11a1 is indirectly activated by lymphocyte enhancer-binding factor 1 (Lef1) and negatively regulates osteoblast maturation.
    Kahler RA; Yingst SM; Hoeppner LH; Jensen ED; Krawczak D; Oxford JT; Westendorf JJ
    Matrix Biol; 2008 May; 27(4):330-8. PubMed ID: 18280717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BMP signaling is required for RUNX2-dependent induction of the osteoblast phenotype.
    Phimphilai M; Zhao Z; Boules H; Roca H; Franceschi RT
    J Bone Miner Res; 2006 Apr; 21(4):637-46. PubMed ID: 16598384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.